IL HB5103

Amends the Illinois Insurance Code Section 356u to expand the definition of "at risk for ovarian cancer" to include having a high level of CA-125 as indicated by blood test screening, in addition to family history and BRCA1/BRCA2 mutations.

Redefines "surveillance tests for ovarian cancer" to mean all medically viable methods for detection and diagnosis, including ultrasounds, MRIs, x-rays, CT scans, and CA-125 blood test screenings, replacing the previous definition of annual screening with specific tests.

Requires group accident and health insurance policies amended, delivered, issued, or renewed after January 1, 2024 to provide coverage without cost-sharing for surveillance tests for ovarian cancer for insureds at risk for the disease.

Expands cervical smear/Pap test coverage to apply to all insureds rather than only female insureds, and clarifies prostate cancer screening eligibility to include individuals (rather than only men) age 40 and over with family history or genetic predisposition to prostate cancer.

Exemption from health savings account disqualification provisions applies to prostate cancer screening coverage, and the requirements do not apply to specified disease or limited benefit coverage policies.